Get CEO.CA Pro
Real-time Level 2 Market Depth
Click for live demo
back
news releases
11 Sep 2023, 08:00
Dr. Karen Chagin Joins Adaptimmune as Senior Vice President of Early-Stage Development $ADAP $473A $US00653A1079
Dr. Karen Chagin Joins Adaptimmune as Senior Vice President of Early-Stage Development $ADAP $473A $US00653A1079
9 Aug 2023, 07:29
Adaptimmune Reports Second Quarter Financial Results and Business Update $ADAP $473A $US00653A1079
Adaptimmune Reports Second Quarter Financial Results and Business Update $ADAP $473A $US00653A1079
3 Aug 2023, 13:24
Adaptimmune to Report Q2 2023 Financial and Business Updates on Wednesday, August 9, 2023 $ADAP $473A $US00653A1079
Adaptimmune to Report Q2 2023 Financial and Business Updates on Wednesday, August 9, 2023 $ADAP $473A $US00653A1079
2 Apr 2019, 08:05
Adaptimmune Presents Safety Data with Evidence of Tumor Necrosis in One Patient from ADP-A2AFP Study at American Association for Cancer Research (AACR) Meeting $ADAP
Adaptimmune Presents Safety Data with Evidence of Tumor Necrosis in One Patient from ADP-A2AFP Study at American Association for Cancer Research (AACR) Meeting $ADAP
show more ▾
featured articles
April 24, 2024
Silver X Delivers Solid Production Growth During the First Quarter of 2024 $AGX $AGXPF.US
Silver X Delivers Solid Production Growth During the First Quarter of 2024 $AGX $AGXPF.US
April 24, 2024
Bitcoin Well Reports 2023 Q4 and Year End Financial Results $BTCW $BCNWF.US
Bitcoin Well Reports 2023 Q4 and Year End Financial Results $BTCW $BCNWF.US
April 24, 2024
Argentina Lithium Announces Positive Lithium Values in the 12th Exploration Well at the Rincon West Project $OAY3 $LILIF.US $LIT
Argentina Lithium Announces Positive Lithium Values in the 12th Exploration Well at the Rincon West Project $OAY3 $LILIF.US $LIT
April 24, 2024
American Eagle: Live Webinar with NAK Geologists Charlie Greig and Neil Prowse on 2024's Drill Program $AMEGF.US $AE $CA02553R1073
American Eagle: Live Webinar with NAK Geologists Charlie Greig and Neil Prowse on 2024's Drill Program $AMEGF.US $AE $CA02553R1073
show more ▾
CEO.CA Chairman's Briefing
Global Markets. Mining Trends. Every Thursday.
read first
Please read the CEO.CA House Rules before posting.
social
legal
Use of this site indicates acceptance of the
Privacy Policy
and
Terms of Use.
The information on this Website is not reliable and not intended to provide tax, legal, or investment advice. Nothing contained on the Website shall be considered a recommendation, solicitation, or offer to buy or sell a security to any person in any jurisdiction.
CEO.CA members discuss high-risk penny stocks which can lose their entire value. Only risk what you can afford to lose.
© 2022 - CEO.CA Technologies Ltd.
Adaptimmune Therapeutics plc
ADAP
$ADAP ↻
0 online
Today
This week
Search
Subscribe
Sign up to become a contributing member of the community.
Trending
Personal channels
